Previous Article | Next Article ![]()
Molecular and Cellular Biology, February 2009, p. 1050-1058, Vol. 29, No. 4
0270-7306/09/$08.00+0 doi:10.1128/MCB.01011-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Department of Molecular Biology and Department of Biochemistry, University of Geneva, CH-1205 Geneva, Switzerland,1 Program in Biochemistry, Biomedical Graduate Studies, University of Pennsylvania, Philadelphia, Pennsylvania 19104,2 Microsystems Laboratory, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland3
Received 27 June 2008/ Returned for modification 12 August 2008/ Accepted 26 November 2008
|
|
|---|
|
|
|---|
53BP1 is one of the DNA damage response proteins that is recruited very efficiently to sites of DNA DSBs. Its recruitment can be visualized either by immunofluorescence of fixed cells or by monitoring live cells expressing 53BP1 fused to green fluorescent protein (GFP). In cells exposed to ionizing radiation (IR), the recruitment of 53BP1 to sites of DNA DSBs becomes evident by its localization to foci that are distributed throughout the nucleus; these foci are thought to correspond to sites of DNA DSBs (4, 20, 30, 33, 44). When DNA damage is induced in specific subnuclear compartments, for example, by UV laser light or by highly charged energetic particles, then 53BP1 localizes to the subnuclear compartments, where the DNA damage was induced (5, 8).
The ability to easily monitor recruitment of 53BP1 to sites of DNA DSBs has allowed significant progress to be made regarding how this protein recognizes DNA damage. Mammalian 53BP1 and its orthologs Rad9 and Crb2/Rhp9, in budding and fission yeast, respectively, recognize DNA DSBs via a tandem tudor domain that binds to methylated histones (18, 31). Human 53BP1 recognizes either methylated K79 of histone H3 or methylated K20 of histone H4 (6, 18, 32, 46), Rad9 recognizes exclusively methylated K79 of histone H3 (13, 43), and Crb2/Rhp9 recognizes exclusively methylated K20 of histone H4 (10, 31). Both K79 of histone H3 and K20 of histone H4 map to the nucleosome core, and their methylation state is apparently not regulated by DNA damage. Instead, it has been proposed that DNA DSBs induce structural changes in chromatin that make these methylated residues accessible (18, 31).
The interaction with methylated histones is critical for recognition of DNA DSBs by 53BP1, Rad9, and Crb2/Rhp9, but for all these three proteins efficient recruitment appears to require additional interactions. Rad9 and Crb2/Rhp9 interact via their BRCT domains with C-terminally phosphorylated histone H2A at DNA damage sites (10, 14, 26, 38). Recruitment of 53BP1 to sites of DNA DSBs is also facilitated by DNA damage-induced phosphorylation of the histone H2A variant H2AX (12, 40), but the BRCT domains of 53BP1 are dispensable (18, 19, 29, 40) and do not bind to phosphorylated histone H2AX (36). Instead, H2AX phosphorylation appears to regulate 53BP1 recruitment indirectly. Specifically, H2AX phosphorylation leads to recruitment of MDC1 (36), which in turn recruits the ubiquitin ligase RNF8; RNF8 then ubiquitinates histones H2A and H2AX, and this ubiquitination facilitates 53BP1 recruitment through an as-yet-unidentified mechanism (17, 22, 24).
In an effort to better understand how 53BP1 is recruited to sites of DNA DSBs, we searched for additional elements within the human protein that are critical for recognition of DNA DSBs. We identify two such elements that together with the tudor domain allow efficient recruitment of 53BP1 to sites of DNA DSBs.
|
|
|---|
IR-induced focus-forming assay. Plasmids encoding GFP-53BP1 fusion proteins were transiently transfected in U2OS osteosarcoma cells using Fugene transfection reagent (Roche Diagnostics, Basel, Switzerland). Two days later the cells were exposed to 3 Gy IR using an X-Rad 320 irradiator (Precision X-Ray, Inc., North Branford, CT) operating at 320 kV and 12.5 mA. Fifteen minutes later the cell medium was replaced with phosphate-buffered saline, and within the next 15 min the intracellular localization of the GFP-53BP1 proteins was monitored by fluorescence microscopy using a 100x water immersion lens (Zeiss, Jena, Germany). Images were acquired with an ORCA ER digital camera (Hamamatsu, Hamamatsu City, Japan) and processed using Imagevision software (Silicon Graphics Inc., Mountain View, CA).
For subnuclear irradiation, we first constructed a pIRESN2 bicistronic vector (Clontech Laboratories, Mountain View, USA) encoding a GFP-53BP1 fusion protein containing residues 1475 to 1635 of human 53BP1 and a heterologous tetramerization domain and used this vector to generate stably transfected U2OS clones. Stably transfected cells were cultured on 18-mm coverslips, which were then placed at the outlet of an X-ray microcollimator (28). The cells were exposed to IR using the X-Rad 320 irradiator operating at 30 kV and 25 mA. At 15 min after irradiation, the cells either were examined live for GFP fluorescence or were fixed and processed for immunofluorescence using antibodies specific for 53BP1 (33) and GFP (Abcam, Cambridge, United Kingdom).
Protein expression and purification and oligomerization assay. Bacterial expression plasmids encoding various 53BP1 fragments with an N-terminal six-histidine tag were generated using a previously described bacterial expression vector (18). Proteins were expressed in Escherichia coli and purified to homogeneity with the aid of nickel chromatography resin (Talon resin; Clontech Laboratories). The proteins were then analyzed for oligomerization by size exclusion chromatography on a Sephadex 200 PC3.2/300 gel filtration column (GE Healthcare Bio-Sciences, Piscataway, NJ).
|
|
|---|
![]() View larger version (33K): [in a new window] |
FIG. 1. Mapping of a 53BP1 region required for efficient IR-induced focus formation. (A) Diagram of the human 53BP1 protein. The boundaries of the tandem tudor and BRCT domains are indicated. The oligomerization domain (OLIG) and the region C terminal to the tudor domain (RCTD) are also indicated (see below). The polypeptide corresponding to amino acids 1220 to 1711 is recruited to sites of DNA DSBs as efficiently as full-length 53BP1. (B to E) Focus-forming activities of GFP-53BP1 fusion proteins containing the indicated residues of human 53BP1. In panels C and E, all deletions were in the context of a polypeptide fragment spanning residues 1231 to 1711 of human 53BP1. The recruitment to IR-induced foci was classified as follows: wild type (+), strong foci with almost no diffuse nucleoplasmic staining; partial (/), visible foci but also clear diffuse nucleoplasmic staining; and none (–), no visible foci. (F) Sequence conservation of residues 1251 to 1271 of human 53BP1. Above the human sequence, the residues that were substituted are indicated by a / or –, depending on whether the substitution compromised or abolished focus formation. 53BP1_hs, Homo sapiens 53BP1; Crb2_sp, S. pombe Crb2; Rad9_ce, Caenorhabditis elegans Rad9; Rad9_sc, S. cerevisiae Rad9. (G) Focus-forming activities of GFP-53BP1 fusion proteins containing residues 1231 to 1711 of human 53BP1 and the indicated amino acid substitutions.
|
Together, the results presented above identified a region between residues 1231 and 1277 that is important for focus formation. To examine the importance of this region in the context of full-length 53BP1, we introduced a deletion of residues 1229 to 1250 in the full-length protein and also in a 53BP1 protein lacking the C-terminal BRCT domains and examined the ability of these proteins to form foci in irradiated cells. In both cases, deletion of residues 1229 to 1250 abolished focus formation in the majority of examined cells (Fig. 1D and E).
After defining the region in human 53BP1 that facilitated efficient recognition of DNA DSBs, we noticed that part of it, corresponding to residues 1251 to 1271, is conserved in evolution (Fig. 1F). In support of the identified homology, replacement of evolutionarily conserved residues, such as Asp1256, Val1260, or Asp1261, with alanine compromised IR-induced focus formation. A double substitution of Tyr1258 and Tyr1259 with alanines, but not the single substitutions, also abolished focus formation (Fig. 1F and G).
53BP1 expressed in mammalian cell lines has been reported to homo-oligomerize in a DNA damage-independent manner, as ascertained by coimmunoprecipitation of ectopically expressed 53BP1 proteins bearing different tags. The region required for oligomerization in vivo maps to residues 1052 to 1475, which includes the region we identified above as being critical for focus formation (2). Because coimmunoprecipitation of 53BP1 proteins with different tags could indicate binding of multiple 53BP1 molecules to some third entity (for example, chromatin) and not necessarily homo-oligomerization, we examined whether 53BP1 contains a homo-oligomerization domain by using an in vitro biochemical assay.
53BP1 polypeptides corresponding to the constructs that were used to examine IR-induced focus formation in vivo (Fig. 1) were expressed in bacteria, purified to homogeneity, and monitored for homo-oligomerization by examining their elution profiles on a gel filtration column (Fig. 2). A 53BP1 polypeptide (amino acids 1231 to 1606, with amino acids 1324 to 1475 deleted) that includes the tandem tudor domain (residues 1485 to 1602) and the newly identified region that facilitates focus formation (residues 1231 to 1277) exhibited an elution profile consistent with homo-oligomerization. In contrast, a polypeptide that differs only by deletion of 10 residues from the N terminus and which did not form foci in vivo eluted from the gel filtration column as a monomer (Fig. 2).
![]() View larger version (22K): [in a new window] |
FIG. 2. Oligomerization of purified human 53BP1 polypeptides in vitro. His-tagged polypeptides containing the indicated residues of human 53BP1 were purified to homogeneity and assayed for oligomerization by size exclusion chromatography. The calculated molecular weight (calc. MW) of each polypeptide (in thousands) is shown to the right, and the elution of molecular weight standards is shown at the bottom. The elution profile of polypeptide 1231-1606 1278-1475 is consistent with an oligomeric form that dissociates into monomers during chromatography.
|
Finally, we also examined the elution profile of a 53BP1 polypeptide (residues 1235 to 1297) just slightly larger than the region that facilitates focus formation. This polypeptide also eluted with a profile indicative of homo-oligomerization (Fig. 2). Thus, these results demonstrate that the novel 53BP1 region, which facilitates focus formation, is a homo-oligomerization domain.
Heterologous oligomerization domains can drive 53BP1 focus formation.
The results presented so far with the various 53BP1 mutants establish a correlation between homo-oligomerization and IR-induced focus formation. To obtain more definitive evidence for the importance of oligomerization, we examined whether heterologous oligomerization domains could rescue focus formation in mutants in which the native 53BP1 oligomerization domain had been deleted (Fig. 3A). We used three different heterologous oligomerization domains (Fig. 3B): a dimeric leucine zipper from the yeast GCN4 transcription factor (LZ), a modified GCN4 leucine zipper that assembles as a tetrameric coiled coil with all
-helices packing in a parallel orientation to each other (TZp), and a hybrid tetramerization domain that consists of the N-terminal half of the human p53 tumor suppressor oligomerization domain fused to the GCN4 leucine zipper and which is expected to have two pairs of parallel
-helices packing antiparallel to each other (TZa). All these oligomerization domains have been characterized previously and their three-dimensional structures have been determined, with the exception of TZa, whose structure, however, can be modeled on the basis of the known structures of its constituent parts (15, 27, 42).
![]() View larger version (30K): [in a new window] |
FIG. 3. Heterologous oligomerization domains can restore the focus-forming activity of GFP-53BP1 fusion proteins lacking the endogenous 53BP1 oligomerization domain. (A) Diagram of the GFP-53BP1 fusion proteins containing a heterologous oligomerization domain between the GFP and 53BP1 sequences and, optionally, also an NLS. LZ, leucine zipper; TZp, modified tetrameric leucine zipper with parallel -helices; TZa, tetramerization domain generated by fusing part of the p53 tetramerization domain to a leucine zipper, resulting in two coiled coils packing antiparallel to each other. (B) Ribbon representations of the three-dimensional structures of segments of the 53BP1 fusion proteins corresponding to the heterologous oligomerization domain and the tandem tudor domain of 53BP1. The images were generated using the programs MOLSCRIPT and RASTER3D from Protein Data Bank files: 2ZTA, GCN4 leucine zipper (LZ); 1GCL, modified tetrameric GCN4 leucine zipper with parallel -helices (TZp); 1C26 and 2ZTA, human p53 tetramerization domain and GCN4 leucine zipper (TZa); and 1XNI, tandem tudor domain of human 53BP1 (TUDOR). (C to E) Focus-forming activities of GFP-53BP1 fusion proteins containing various segments of human 53BP1 and, optionally, a heterologous oligomerization domain and/or a D1521R substitution in the 53BP1 tudor domain, as indicated. Focus-forming activities were classified as described in the legend to Fig. 1.
|
A short conserved region C terminal to the tudor domain is also required for 53BP1 focus formation. All the GFP-53BP1 fusion constructs described so far contain 53BP1 fragments that extend up to residue 1711 of human 53BP1, whereas the C terminus of the tudor domain extends only up to residue 1602 (7, 18). The 109 amino acids C terminal to the tudor domain contain a nuclear localization signal (NLS), but whether they contain additional elements that are critical for IR-induced focus formation has not been examined. In the context of a GFP-53BP1 fusion protein containing the tetrameric coiled coil as an oligomerization domain and amino acids 1475 to 1711 of human 53BP1 (GFP-TZp-53BP1 1475-1711), we introduced C-terminal deletions and examined their effect on recruitment to IR-induced foci. Fusion proteins containing amino acids 1475 to 1635 and 1475 to 1631 of 53BP1 were nuclear and formed IR-induced foci, whereas a fusion protein containing amino acids 1475 to 1627 of 53BP1 was cytoplasmic (Fig. 4A). Thus, residues 1632 to 1711 are not required for focus formation, and the 53BP1 NLS maps just N terminal to residue 1631.
![]() View larger version (44K): [in a new window] |
FIG. 4. An element corresponding to residues 1614 to 1629 of human 53BP1 is also required for efficient IR-induced focus formation. (A and B) Focus-forming activities of GFP-53BP1 fusion proteins containing various segments of human 53BP1, the modified tetrameric GCN4 leucine zipper (TZp), and, optionally, an NLS (N), as indicated. 0 Gy, nonirradiated cells. (C) Focus-forming activities of GFP-NLS-TZp-53BP1 fusion proteins containing residues 1451 to 1631 of human 53BP1 and the indicated amino acid substitutions. (D) Focus-forming activities of GFP-full-length 53BP1 fusion proteins containing the indicated amino acid substitutions. (E) Sequence conservation of residues 1591 to 1631 of human 53BP1. Above the human sequence, the residues that were substituted are indicated by a +, /, or –, depending on whether the substitution did not affect, compromised, or abolished focus formation. The C-terminal boundary of the tudor domain at residue 1602 and the boundaries of the RCTD are also shown. 53BP1 sequences are from the following species: hs, Homo sapiens; gg, Gallus gallus; xl, Xenopus laevis; tn, Tetraodon nigroviridis; dr, Danio rerio; sp, Strongylocentrotus purpuratus. (F) Sequences of the C termini of GFP-NLS-TZp-53BP1 fusion proteins with small segments of 53BP1 replaced with residues 734 to 754 of human NBS1, residues 259 to 276 of S. cerevisiae VPS27, or residues 106 to 123 of human RAP80, as indicated. The NBS1, VPS27, and RAP80 segments are in bold letters and underlined. Asterisks indicate the free C-terminal ends of the fusion proteins. (G) Focus-forming activities of the GFP-NLS-TZp-53BP1 fusion proteins containing the human NBS1, S. cerevisiae VPS27, or human RAP80 sequences. (H) The tandem tudor domain and the RCTD function as one unit. GFP-NLS-TZp-53BP1 fusion proteins containing residues 1451 to 1631 of human 53BP1 and, optionally, amino acid substitutions targeting the tudor domain (D1521R) and/or the RCTD (L1619E) were expressed in cells and scored for IR-induced focus formation, as indicated. wt, expression of a wild-type 1451-1631 human 53BP1 fragment; wt + dm, coexpression of wild-type and double mutant (D1521R and L1619E) human 53BP1 fragments; sm + sm, coexpression of single mutant D1521R and L1619E human 53BP1 fragments.
|
To map more finely the residues that are functionally important in this region, single amino acid substitutions were introduced in the GFP-TZp-53BP1 fusion protein. Targeting A1607, P1610, and L1611 did not affect focus formation; targeting A1614, A1615, S1618, and R1629 compromised focus formation; and targeting L1619 and L1622 abolished focus formation (Fig. 4C). The substitutions targeting L1619 and L1622 also abolished focus formation in the context of full-length 53BP1 (Fig. 4D). Taken together, these results define residues 1614 to 1629 as a region that facilitates focus formation. Alignment of the sequences of 53BP1 proteins from several species revealed that this region, which we refer to as the region C terminal to the tudor domain (RCTD), is conserved in higher eukaryotes (Fig. 4E). However, in lower eukaryotes we could not identify an RCTD-like sequence.
The sequence of the RCTD did not provide clues to its function. The conserved serine (S1618) in this region could in principle be phosphorylated, and this phosphorylation could mediate interaction with other proteins at sites of DNA DSBs. However, replacement of S1618 with alanine was compatible with focus formation (Fig. 4C), arguing against this possibility. We also noted weak sequence homology of this region to the C terminus of human NBS1 (the region that interacts with ATM [11]) and also to the ubiquitin interaction motifs (UIM) present in Saccharomyces cerevisiae vacuolar protein sorting protein 27 (VPS27) (37) and in the human receptor-associated protein 80 (RAP80) (the UIM in RAP80 is important for its recruitment to sites of DNA DSBs [21, 34, 39, 45]). To test whether these weak sequence homologies were functionally relevant, we replaced 53BP1 residues C terminal to the tudor domain with the homologous residues from the NBS1, VPS27, or RAP80 proteins mentioned above (Fig. 4F) and then examined for focus-forming activity in irradiated cells. As shown, none of these fusion proteins formed foci after irradiation (Fig. 4G).
Finally, we examined whether the function of the RCTD requires that it be in cis (on the same polypeptide) with the tudor domain or whether it can function in trans. We took advantage of the fact that 53BP1 forms homo-oligomers and generated mutants in which amino acid substitutions in the tudor domain and in the RCTD were present either in the same polypeptide or in different polypeptides. Further, to avoid interference with endogenous 53BP1, these substitutions were introduced in 53BP1 polypeptides fused to the parallel tetrameric zipper in place of the endogenous 53BP1 oligomerization domain (Fig. 4H). We observed IR-induced 53BP1 foci in all cells expressing a 1:1 ratio of wild-type 53BP1 and a 53BP1 mutant having substitutions in both the tudor domain and the RCTD. However, in cells expressing a 1:1 ratio of a mutant with a substitution in the tudor domain and a mutant with a substitution in the RCTD, 53BP1 foci were absent (Fig. 4H). Thus, we conclude that the tudor domain and RCTD represent one functional unit.
Validation that the ability of the GFP-53BP1 fusion proteins to form foci in irradiated cells indicates recruitment to DNA DSBs. Throughout this project, we have considered the ability of the various GFP-53BP1 fusion proteins to form IR-induced foci to be synonymous with recruitment to sites of DNA DSBs. To verify that this is indeed the case, we developed an X-ray collimator that can limit the irradiated field to areas whose smallest dimension is in the micrometer range (28). This microcollimator consists of silicon plates with dimensions of 1 cm by 2 cm by 380 µm. On their surfaces the silicon plates have grooves that are 1 µm deep and run the entire length of the plate (Fig. 5A). Stacking of multiple such plates results in the formation of 1-µm-wide channels (Fig. 5A) that can be used to irradiate subnuclear compartments (Fig. 5B).
![]() View larger version (50K): [in a new window] |
FIG. 5. A minimized GFP-53BP1 fusion protein forms IR-induced foci only in irradiated subnuclear compartments. (A and B) Design of the X-ray microcollimator. Silicon wafers with 1-µm-deep grooves on one of their long surfaces are stacked against each other, such that 1-µm-wide channels are formed between the plates. (A) Cross section of one wafer (top) and of several stacked wafers (bottom). (B) Position of the silicon wafers between an X-ray source and the cells to be irradiated. For clarity, only a single wafer is shown, rather than a stack of wafers. (C and D) Formation of IR-induced foci of a GFP-TZp-53BP1 fusion protein containing residues 1475 to 1635 of human 53BP1 in irradiated subnuclear compartments. The interrupted dark blue line indicates the area exposed to IR. (C) Analysis of live cells by monitoring GFP fluorescence. (D) Analysis of fixed cells by immunofluorescence for endogenous 53BP1 and for the GFP-TZp-53BP1 fusion protein. The antibody that recognizes endogenous 53BP1 does not recognize the GFP-TZp-53BP1 fusion protein. Light blue lines mark the nuclei of the cells.
|
|
|
|---|
The presence of an oligomerization domain in human 53BP1 was previously documented using a coimmunoprecipitation assay performed with extracts of cells expressing two differentially tagged 53BP1 proteins. Using this assay, the oligomerization domain was mapped within residues 1052 to 1475 (2). A subsequent study further refined the boundaries of the oligomerization domain to residues 1231 to 1270 but paradoxically also reported that this domain was not required for 53BP1 focus formation (41). Aware of these findings, we pursued our efforts to identify regions that are important for 53BP1 focus formation in an unbiased manner and made a comprehensive series of 53BP1 deletion proteins. When we concluded this analysis, the results showed that the boundaries of one of the domains needed for efficient focus formation matched precisely the boundaries of the oligomerization domain. In fact, 53BP1 proteins that are unable to oligomerize, such as proteins spanning residues 1251 to 1711 of human 53BP1, failed to form IR-induced foci, even when the endogenous 53BP1 protein was depleted (data not shown), suggesting that they cannot localize to sites of DNA DSBs, even in the absence of competition by endogenous oligomeric 53BP1. Two additional observations support our conclusion that oligomerization is critical for 53BP1 focus formation. First, the ability of purified 53BP1 polypeptides to form oligomers in vitro correlated precisely with focus-forming activity in vivo, and second, the endogenous 53BP1 oligomerization domain could be replaced with heterologous oligomerization domains.
What are the implications of oligomerization for recognition of sites of DNA DSBs by 53BP1? We speculate that changes in chromatin structure at sites of DNA DSBs expose multiple 53BP1-binding sites. As a result, a 53BP1 homo-oligomer will exhibit greater avidity than monomeric 53BP1 for chromatin at sites of DNA DSBs, akin to the example of antibodies which have two antigen-binding sites. It is also possible that oligomerization allows 53BP1 to recognize more than one methylated residue in the histone core, since the tudor domain of mammalian 53BP1 can recognize both histone H3 methylated on K79 and histone H4 methylated on K20 (6, 18, 32, 46).
Whether oligomerization is also important for recruitment of yeast 53BP1 homologs to IR-induced foci remains to be established. The oligomerization domain of human 53BP1 has weak homology to sequences present in Schizosaccharomyces pombe Crb2 and S. cerevisiae Rad9 (Fig. 1F), but it is not known if these sequences constitute oligomerization domains. Irrespective of whether they do or not, both Crb2 and Rad9 homo-oligomerize through protein-protein interactions mediated by their BRCT domains. Deleting the BRCT domains abolishes association with damaged chromatin (9, 10, 14, 26, 35), but at least for Crb2, replacing its BRCT domains with a leucine zipper does not restore IR-induced focus formation (9, 10). This indicates that the BRCT domains mediate an activity beyond oligomerization. Indeed, the BRCT domains of both Crb2 and Rad9 bind to phosphorylated histone H2A, and this binding is critical for recruitment to sites of DNA DSBs (10, 14, 26, 38). In contrast, the BRCT domains of human 53BP1 do not bind to phosphorylated H2AX (36), and deleting them does not compromise 53BP1 focus formation (18, 19, 29, 40).
The second region of human 53BP1 that facilitates IR-induced focus formation corresponds to residues 1614 to 1629 and is located just 12 amino acids after the C-terminal end of the tandem tudor domain. This region, which we refer to as RCTD, is conserved from human to sea urchin but is not discernible in yeast (Fig. 4E). We explored whether the RCTD functions as a ubiquitin-binding module, because histone H2A/H2AX ubiquitination is critical for 53BP1 focus formation (17, 22, 24). However, replacing this region with the UIM of human RAP80 or S. cerevisiae VPS27 did not rescue IR-induced focus formation, despite the fact that in RAP80 the UIM is critical for recruitment to sites of DNA damage (21, 34, 39, 45). We also explored the possibility that this region of 53BP1 may be related to the ATM-binding C terminus of NBS1, on the basis of a weak sequence homology between 53BP1 and NBS1. However, replacing residues 1615 to 1631 of human 53BP1 with the ATM-binding region of NBS1 also did not rescue focus formation. Nevertheless, we did show that the RCTD functions as one unit with the tudor domain. This could reflect a requirement of the RCTD for native folding of the tudor domain. However, structural studies of 53BP1 polypeptides containing the tandem tudor domain with or without the RCTD show that the RCTD itself is unstructured and has no effect on the three-dimensional structure of the tandem tudor domain (7, 18). Thus, the most likely possibility is that the RCTD facilitates focus formation by interacting with some component of chromatin adjacent to the tudor-binding site in the histone core, possibly DNA (3, 7, 23).
Finally, we utilized a newly developed microcollimator for X rays (28) to document that the IR-induced foci of the GFP-53BP1 fusion proteins indeed represent sites of DNA DSBs. IR-induced foci of endogenous 53BP1 were originally considered to represent sites of DNA DSBs on the basis of their colocalization with foci of phosphorylated histone H2AX and foci of NBS1 (4, 30, 33, 44). More recently, endogenous 53BP1 and GFP-53BP1 fusions proteins were shown to localize to subnuclear compartments, in which DNA damage was induced either by UV lasers or by highly charged energetic Fe particles (5, 8). By exposing micrometer-wide strips of cells to X rays, we unambiguously showed that 53BP1 foci form only in parts of cell nuclei that have been exposed to X rays. Further, a fusion protein containing residues 1475 to 1635 of human 53BP1 fused to a heterologous oligomerization domain also forms foci only in parts of the cell nuclei that have been irradiated, thus validating the analysis of the domains of 53BP1 required for efficient focus formation.
Published ahead of print on 8 December 2008. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»